Effectiveness of a peer-refugee delivered psychological intervention to reduce psychological distress among adult Syrian refugees in the Netherlands: study protocol

de Graaff, Anne M., Cuijpers, Pim, Acarturk, Ceren, Bryant, Richard, Burchert, Sebastian, Fuhr, Daniela C., Huizink, Anja C., de Jong, Joop, Kieft, Barbara, Knaevelsrud, Christine, McDaid, David ORCID: 0000-0003-0744-2664, Morina, Naser, Park, A-La ORCID: 0000-0002-4704-4874, Uppendahl, Jana, Ventevogel, Peter, Whitney, Claire, Wiedemann, Nana, Woodward, Aniek and Sijbrandij, Marit (2020) Effectiveness of a peer-refugee delivered psychological intervention to reduce psychological distress among adult Syrian refugees in the Netherlands: study protocol. European Journal of Psychotraumatology, 11 (1). ISSN 2000-8198

Text (McDaid_effectiveness-of-peer-refugee-delivered-psychological-intervention--published) - Published Version Available under License Creative Commons Attribution Non-commercial. Download (3MB)

• Scopus publication
• Author
• Author

Abstract

Background: Syrian refugees face multiple hardships and adversities which put them at risk for the development of mental health problems. However, access to adequate mental health care in host countries is limited. The WHO has developed Problem Management Plus (PM+), a brief, scalable psychological intervention, delivered by non-specialist helpers, that addresses common mental disorders in people affected by adversity. This study is part of the STRENGTHS project, that aims to evaluate peer-refugee delivered psychological interventions for Syrian refugees in Europe and the Middle East. Objective: To evaluate the effectiveness and cost-effectiveness of the peer-refugee delivered PM+ intervention among Syrian refugees with elevated levels of psychological distress in the Netherlands. Methods: PM+ will be tested in a randomized controlled trial (RCT) among Arabic-speaking Syrian refugees in the Netherlands aged 18 years and above with self-reported psychological distress (Kessler Psychological Distress Scale; K10 >15) and impaired daily functioning (WHO Disability Assessment Schedule; WHODAS 2.0 >16). Participants (N = 380) will be randomized into care as usual with PM+ (CAU/PM+, n = 190) or CAU only (CAU, n = 190). Baseline, 1-week post-intervention, and 3-month and 12-month follow-up assessments will be conducted. Primary outcomes are symptoms of depression and anxiety. Secondary outcomes are functional impairment, posttraumatic stress disorder symptoms, self-identified problems, anger, health and productivity costs, and hair cortisol concentrations. A process evaluation will be carried out to evaluate treatment dose, protocol fidelity and stakeholder views on barriers and facilitators to implementing PM+. Results and Conclusions: PM+ has proved effectiveness in other populations and settings. After positive evaluation, the adapted manual and training materials for individual PM+ will be made available through the WHO to encourage further replication and scaling up. Trial registration: Trial registration Dutch Trial Registry, NL7552, registered prospectively on March 1, 2019. Medical Ethics Review Committee VU Medical Center Protocol ID 2017.320, 7 September 2017.

Item Type:	Article
Official URL:	https://www.tandfonline.com/toc/zept20/current
Additional Information:	© 2020 The Authors
Divisions:	Care Policy and Evaluation Centre
Subjects:	R Medicine > RA Public aspects of medicine B Philosophy. Psychology. Religion > BF Psychology
Date Deposited:	05 Feb 2020 10:18
Last Modified:	15 Nov 2024 03:30
URI:	http://eprints.lse.ac.uk/id/eprint/103295

Actions (login required)

View Item